Start for free

Fermenta Biotech Limited

NSE: FERMENTAHealthcare

Fermenta Biotech Limited Share Price & Analysis

₹498.50−0.76%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹498.50−0.76%
Open
₹500.70
High
₹509.35
Low
₹491.65
Close
₹498.50
52W High
₹580.45
52W Low
₹248.85
Volume
101K
Lot Size
1
Sector
Healthcare
Market Cap
₹1K Cr
Face Value
₹5
Small Cap

Price Chart

Candle
Range

Fundamentals

P/E
26.80
Sector P/E
54.70
P/B
3.39
EPS
₹29.55
ROE
16.40%
ROCE
20.60%
D/E Ratio
0.28
Div Yield
0.75%
Book Value
₹138.00

Strengths

  • Strong return on equity (ROE 16.4%)
  • Efficient capital deployment (ROCE 20.6%)
  • Attractively valued vs sector (P/E 26.8x vs industry 54.7x)
  • Low debt relative to equity (D/E 0.3x)

Concerns

    Peer Comparison

    CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
    SUNPHARMA
    Sun Pharmaceutical Industries Limited
    ₹1,899
    		₹4.6L Cr36.15.461620.50.07
    DIVISLAB
    Divi's Laboratories Limited
    ₹9,100
    		₹2.4L Cr81.114.4216.5220.01
    TORNTPHARM
    Torrent Pharmaceuticals Limited
    ₹4,857
    		₹1.8L Cr82.819.5827.415.20.33
    APOLLOHOSP
    Apollo Hospitals Enterprise Limited
    ₹8,650
    		₹1.2L Cr59.113.1321.217.40.88
    CIPLA
    Cipla Limited
    ₹1,385
    		₹1.1L Cr31.33.2511.615.50.01
    ZYDUSLIFE
    Zydus Lifesciences Limited
    ₹1,120
    		₹1.1L Cr234.1621.221.10.38
    LAURUSLABS
    Laurus Labs Limited
    ₹1,840
    		₹99K Cr90.918.7418.317.80.46

    Showing 7 peers in the same sector · Sorted by market cap

    Shareholding Pattern

    FERMENTA · as of Mar 2026

    Promoters64.08%2.02pp
    FII0.02%
    Public35.00%1.98pp
    Others0.89%0.05pp
    CategoryDec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
    Promoters62.06%62.06%62.06%62.06%62.06%64.08%
    FII———0.05%0.02%0.02%
    Public36.05%36.05%36.11%36.41%36.98%35.00%
    Others1.89%1.89%1.82%1.47%0.94%0.89%

    Latest News

    All news

    Fermenta Biotech reports Q1 FY26 financial results

    *Fermenta Biotech reports Q1 FY26 financial results.* The company has submitted unaudited standalone and consolidated financial results for the quarter ended June 30, 2026. Results include key performance metrics and financial health updates relevant to investors. No major deviations or surprises were highlighted in the filing. 📊 *STOCKS:* FERMENTA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings

    NSE Filing11 Aug
    High Impact

    Fermenta Biotech announces unaudited Q1FY27 financial results

    *Fermenta Biotech announces unaudited Q1FY27 financial results*. Fermenta Biotech has released its unaudited financial results for the first quarter of FY27. The report provides insights into the company's performance, though specific figures like revenue and net profit were not detailed in the announcement. Traders may assess margins and cost trends once full data is available. The stock could see volatility on earnings sentiment. 📊 *STOCKS:* FERMENTA | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #Earnings

    NSE Filing11 Aug
    Medium Impact

    Fermenta Biotech to hold 74th Annual General Meeting

    *Fermenta Biotech to hold its 74th Annual General Meeting for shareholders.* The event is a routine corporate update with no major announcements. Details on financials or strategy may emerge during the meeting. 📊 *STOCKS:* $FERMENTA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM

    NSE Filing11 Aug
    Low Impact

    Fermenta Biotech shares may react to investor presentation

    *Fermenta Biotech shares may react to investor presentation.* The company released an investor presentation via a corporate filing on NSE. Such updates typically provide insights into strategy and performance but lack immediate financial triggers. **No major financial figures or announcements** were highlighted in the summary. 📊 *STOCKS:* $FERMENTA | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorPresentation

    NSE Filing11 Aug
    Low Impact

    Financials

    Quarterly Results

    MetricDec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    Revenue
    ₹137 Cr
    5.4%
    ₹130 Cr
    4.4%
    ₹136 Cr
    2.9%
    ₹140 Cr
    10.3%
    ₹156 Cr
    64.2%
    ₹95 Cr
    21.8%
    ₹78 Cr
    19.6%
    ₹97 Cr
    Op. Profit
    ₹25 Cr
    7.4%
    ₹27 Cr
    3.6%
    ₹28 Cr
    24.3%
    ₹37 Cr
    30.2%
    ₹53 Cr
    178.9%
    ₹19 Cr
    1800.0%
    ₹1 Cr
    80.0%
    ₹5 Cr
    OPM
    18.0%
    10.0%
    20.0%
    4.8%
    21.0%
    19.2%
    26.0%
    23.5%
    34.0%
    70.0%
    20.0%
    1900.0%
    1.0%
    83.3%
    6.0%
    Net Profit
    ₹12 Cr
    33.3%
    ₹18 Cr
    18.2%
    ₹22 Cr
    33.3%
    ₹33 Cr
    13.2%
    ₹38 Cr
    245.5%
    ₹11 Cr
    283.3%
    ₹-6 Cr
    14.3%
    ₹-7 Cr
    EPS (₹)
    4.31
    29.8%
    6.14
    17.3%
    7.42
    36.5%
    11.68
    6.9%
    12.54
    224.0%
    3.87
    295.5%
    -1.98
    16.1%
    -2.36

    Values in ₹ Cr · Source: Screener.in

    Annual Profit & Loss

    MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Revenue
    ₹525 Cr
    12.2%
    ₹468 Cr
    39.7%
    ₹335 Cr
    4.0%
    ₹349 Cr
    12.1%
    ₹397 Cr
    5.6%
    ₹376 Cr
    28.8%
    ₹292 Cr
    27.5%
    ₹403 Cr
    33.4%
    ₹302 Cr
    84.1%
    ₹164 Cr
    Expenses
    ₹426 Cr
    21.0%
    ₹352 Cr
    14.7%
    ₹307 Cr
    7.0%
    ₹330 Cr
    1.5%
    ₹335 Cr
    14.3%
    ₹293 Cr
    30.2%
    ₹225 Cr
    9.3%
    ₹248 Cr
    18.7%
    ₹209 Cr
    37.5%
    ₹152 Cr
    Op. Profit
    ₹100 Cr
    13.0%
    ₹115 Cr
    310.7%
    ₹28 Cr
    55.6%
    ₹18 Cr
    71.0%
    ₹62 Cr
    25.3%
    ₹83 Cr
    25.8%
    ₹66 Cr
    57.7%
    ₹156 Cr
    67.7%
    ₹93 Cr
    675.0%
    ₹12 Cr
    OPM
    19.0%
    24.0%
    25.0%
    212.5%
    8.0%
    60.0%
    5.0%
    68.8%
    16.0%
    27.3%
    22.0%
    4.3%
    23.0%
    41.0%
    39.0%
    25.8%
    31.0%
    342.9%
    7.0%
    Other Income
    ₹29 Cr
    314.3%
    ₹7 Cr
    75.0%
    ₹4 Cr
    120.0%
    ₹-20 Cr
    350.0%
    ₹8 Cr
    0.0%
    ₹8 Cr
    33.3%
    ₹12 Cr
    100.0%
    ₹6 Cr
    33.3%
    ₹9 Cr
    200.0%
    ₹3 Cr
    Interest
    ₹12 Cr
    20.0%
    ₹15 Cr
    11.8%
    ₹17 Cr
    19.0%
    ₹21 Cr
    16.7%
    ₹18 Cr
    5.3%
    ₹19 Cr
    5.0%
    ₹20 Cr
    4.8%
    ₹21 Cr
    50.0%
    ₹14 Cr
    40.0%
    ₹10 Cr
    Depreciation
    ₹22 Cr
    8.3%
    ₹24 Cr
    4.0%
    ₹25 Cr
    10.7%
    ₹28 Cr
    7.7%
    ₹26 Cr
    30.0%
    ₹20 Cr
    33.3%
    ₹15 Cr
    25.0%
    ₹12 Cr
    0.0%
    ₹12 Cr
    20.0%
    ₹10 Cr
    PBT
    ₹96 Cr
    15.7%
    ₹83 Cr
    930.0%
    ₹-10 Cr
    80.4%
    ₹-51 Cr
    288.9%
    ₹27 Cr
    48.1%
    ₹52 Cr
    20.9%
    ₹43 Cr
    66.7%
    ₹129 Cr
    69.7%
    ₹76 Cr
    1366.7%
    ₹-6 Cr
    Tax %
    27.0%
    237.5%
    8.0%
    94.4%
    143.0%
    3475.0%
    4.0%
    90.9%
    44.0%
    144.4%
    18.0%
    148.6%
    -37.0%
    562.5%
    8.0%
    71.4%
    28.0%
    42.9%
    49.0%
    Net Profit
    ₹70 Cr
    7.9%
    ₹76 Cr
    416.7%
    ₹-24 Cr
    54.7%
    ₹-53 Cr
    453.3%
    ₹15 Cr
    65.1%
    ₹43 Cr
    28.3%
    ₹60 Cr
    48.7%
    ₹117 Cr
    154.3%
    ₹46 Cr
    611.1%
    ₹-9 Cr
    EPS (₹)
    24.39
    6.6%
    26.12
    433.2%
    -7.84
    54.8%
    -17.36
    430.7%
    5.25
    66.0%
    15.46
    23.6%
    20.23
    52.6%
    42.71
    249.8%
    12.21
    394.9%
    -4.14
    Div Payout
    15.0%
    66.7%
    9.0%
    156.3%
    -16.0%
    128.6%
    -7.0%
    130.4%
    23.0%
    43.8%
    16.0%
    33.3%
    24.0%
    2300.0%
    1.0%
    50.0%
    2.0%
    140.0%
    -5.0%

    Values in ₹ Cr · Source: Screener.in

    Balance Sheet

    ItemSep 2025Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017
    Liabilities
    Equity Capital
    ₹15 Cr
    0.0%
    ₹15 Cr
    7.1%
    ₹14 Cr
    0.0%
    ₹14 Cr
    0.0%
    ₹14 Cr
    0.0%
    ₹14 Cr
    0.0%
    ₹14 Cr
    180.0%
    ₹5 Cr
    150.0%
    ₹2 Cr
    0.0%
    ₹2 Cr
    Reserves
    ₹376 Cr
    8.0%
    ₹348 Cr
    27.0%
    ₹274 Cr
    9.0%
    ₹301 Cr
    15.9%
    ₹358 Cr
    3.5%
    ₹346 Cr
    17.3%
    ₹295 Cr
    19.9%
    ₹246 Cr
    101.6%
    ₹122 Cr
    14.1%
    ₹142 Cr
    Borrowings
    ₹112 Cr
    2.6%
    ₹115 Cr
    17.3%
    ₹139 Cr
    36.8%
    ₹220 Cr
    7.9%
    ₹239 Cr
    3.0%
    ₹232 Cr
    3.6%
    ₹224 Cr
    7.2%
    ₹209 Cr
    20.8%
    ₹173 Cr
    98.9%
    ₹87 Cr
    Other Liabilities
    ₹149 Cr
    8.8%
    ₹137 Cr
    14.2%
    ₹120 Cr
    17.6%
    ₹102 Cr
    6.3%
    ₹96 Cr
    2.1%
    ₹94 Cr
    17.5%
    ₹80 Cr
    13.0%
    ₹92 Cr
    5.7%
    ₹87 Cr
    16.0%
    ₹75 Cr
    Total Liabilities
    ₹651 Cr
    6.0%
    ₹614 Cr
    12.0%
    ₹548 Cr
    14.0%
    ₹637 Cr
    9.9%
    ₹707 Cr
    2.9%
    ₹687 Cr
    11.9%
    ₹614 Cr
    11.4%
    ₹551 Cr
    43.1%
    ₹385 Cr
    25.4%
    ₹307 Cr
    Assets
    Fixed Assets
    ₹219 Cr
    3.5%
    ₹227 Cr
    15.6%
    ₹269 Cr
    0.7%
    ₹267 Cr
    10.7%
    ₹299 Cr
    13.7%
    ₹263 Cr
    31.5%
    ₹200 Cr
    12.4%
    ₹178 Cr
    0.6%
    ₹177 Cr
    2.9%
    ₹172 Cr
    CWIP
    ₹26 Cr
    62.5%
    ₹16 Cr
    700.0%
    ₹2 Cr
    95.6%
    ₹45 Cr
    28.6%
    ₹35 Cr
    38.6%
    ₹57 Cr
    19.7%
    ₹71 Cr
    222.7%
    ₹22 Cr
    450.0%
    ₹4 Cr
    20.0%
    ₹5 Cr
    Investments
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    100.0%
    ₹3 Cr
    ₹0 Cr
    ₹0 Cr
    ₹0 Cr
    100.0%
    ₹8 Cr
    20.0%
    ₹10 Cr
    44.4%
    ₹18 Cr
    Other Assets
    ₹406 Cr
    9.1%
    ₹372 Cr
    34.3%
    ₹277 Cr
    13.7%
    ₹321 Cr
    13.9%
    ₹373 Cr
    1.6%
    ₹367 Cr
    7.3%
    ₹342 Cr
    0.6%
    ₹344 Cr
    78.2%
    ₹193 Cr
    72.3%
    ₹112 Cr
    Total Assets
    ₹651 Cr
    6.0%
    ₹614 Cr
    12.0%
    ₹548 Cr
    14.0%
    ₹637 Cr
    9.9%
    ₹707 Cr
    2.9%
    ₹687 Cr
    11.9%
    ₹614 Cr
    11.4%
    ₹551 Cr
    43.1%
    ₹385 Cr
    25.4%
    ₹307 Cr

    Values in ₹ Cr · Source: Screener.in

    Cash Flow Statement

    ItemMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
    Operating CF
    ₹41 Cr
    61.0%
    ₹105 Cr
    9.5%
    ₹116 Cr
    169.8%
    ₹43 Cr
    31.7%
    ₹63 Cr
    85.3%
    ₹34 Cr
    62.2%
    ₹90 Cr
    52.5%
    ₹59 Cr
    2850.0%
    ₹2 Cr
    50.0%
    ₹4 Cr
    Investing CF
    ₹0 Cr
    100.0%
    ₹-16 Cr
    70.9%
    ₹-55 Cr
    111.5%
    ₹-26 Cr
    36.6%
    ₹-41 Cr
    6.8%
    ₹-44 Cr
    54.6%
    ₹-97 Cr
    4.0%
    ₹-101 Cr
    1542.9%
    ₹7 Cr
    153.8%
    ₹-13 Cr
    Financing CF
    ₹-51 Cr
    44.0%
    ₹-91 Cr
    122.0%
    ₹-41 Cr
    86.4%
    ₹-22 Cr
    2100.0%
    ₹-1 Cr
    97.9%
    ₹-47 Cr
    491.7%
    ₹12 Cr
    86.5%
    ₹89 Cr
    841.7%
    ₹-12 Cr
    220.0%
    ₹10 Cr
    Net Cash Flow
    ₹-10 Cr
    900.0%
    ₹-1 Cr
    105.3%
    ₹19 Cr
    575.0%
    ₹-4 Cr
    119.0%
    ₹21 Cr
    136.8%
    ₹-57 Cr
    1050.0%
    ₹6 Cr
    87.2%
    ₹47 Cr
    1275.0%
    ₹-4 Cr
    500.0%
    ₹1 Cr
    Free Cash Flow
    ₹38 Cr
    55.8%
    ₹86 Cr
    13.2%
    ₹76 Cr
    1166.7%
    ₹6 Cr
    14.3%
    ₹7 Cr
    120.6%
    ₹-34 Cr
    161.8%
    ₹55 Cr
    31.0%
    ₹42 Cr
    347.1%
    ₹-17 Cr
    32.0%
    ₹-25 Cr

    Values in ₹ Cr · Source: Screener.in

    Key Ratios History

    MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
    Debtor Days
    74d
    2.6%
    76d
    72.7%
    44d
    45.0%
    80d
    21.2%
    66d
    24.1%
    87d
    47.5%
    59d
    28.9%
    83d
    16.2%
    99d
    2.0%
    101d
    Inventory Days
    306d
    24.9%
    245d
    20.7%
    309d
    18.7%
    380d
    13.8%
    441d
    25.8%
    594d
    71.2%
    347d
    48.3%
    234d
    12.5%
    208d
    30.0%
    160d
    Days Payable
    192d
    5.5%
    182d
    67.0%
    109d
    29.2%
    154d
    8.9%
    169d
    35.0%
    260d
    53.8%
    169d
    7.7%
    183d
    24.5%
    147d
    30.1%
    113d
    Cash Conv. Cycle
    189d
    36.0%
    139d
    43.0%
    244d
    20.3%
    306d
    9.5%
    338d
    19.7%
    421d
    77.6%
    237d
    76.9%
    134d
    16.3%
    160d
    8.1%
    148d
    Working Capital Days
    40d
    344.4%
    9d
    150.0%
    -18d
    126.9%
    67d
    24.1%
    54d
    22.9%
    70d
    62.8%
    43d
    20.4%
    54d
    63.6%
    33d
    167.3%
    -49d
    ROCE
    23.0%
    666.7%
    3.0%
    0.0%
    100.0%
    7.0%
    46.2%
    13.0%
    8.3%
    12.0%
    70.7%
    41.0%
    32.3%
    31.0%
    1450.0%
    2.0%
    66.7%
    6.0%

    Source: Screener.in · Lower days = better efficiency

    About Fermenta Biotech Limited

    Incorporated in 1951, Fermenta Biotech Ltd manufactures Active Pharmaceutical Ingredient, Aqua CHL, Biotechnology and Nutraceutical products[1]

    HealthcarePharmaceuticals & Biotechnology

    Related Analysis

    Same Sector

    ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

    Frequently Asked Questions

    What is Fermenta Biotech Limited share price today?
    Fermenta Biotech Limited (FERMENTA) is currently trading at ₹498.5 on NSE, down 0.76% as of the last market session. Prices update daily after market close on MarketNetra.
    Is Fermenta Biotech Limited available in F&O (Futures & Options)?
    Yes, Fermenta Biotech Limited (FERMENTA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
    What is Fermenta Biotech Limited 52-week high and low?
    Fermenta Biotech Limited's 52-week high is ₹580.45 and the 52-week low is ₹248.85. The current price of ₹498.5 is 14.1% below the 52W high.
    What is Fermenta Biotech Limited P/E ratio?
    Fermenta Biotech Limited's current P/E ratio is 26.8. This indicates the market is paying ₹26.8 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
    How to trade Fermenta Biotech Limited options?
    Fermenta Biotech Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade FERMENTA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.